ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Federal Home Loan Mortgage Corporation (QB)

Federal Home Loan Mortgage Corporation (QB) (FMCKM)

8.43
0.38
(4.72%)
Closed December 05 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
8.43
Bid
8.15
Ask
8.45
Volume
1,551
8.11 Day's Range 8.45
1.70 52 Week Range 8.85
Market Cap
Previous Close
8.05
Open
8.11
Last Trade
50
@
8.43
Last Trade Time
Financial Volume
$ 13,062
VWAP
8.4214
Average Volume (3m)
97,176
Shares Outstanding
650,059,553
Dividend Yield
-
PE Ratio
-8.46
Earnings Per Share (EPS)
-0.26
Revenue
18.37B
Net Profit
-166M

About Federal Home Loan Mortgage Corporation (QB)

Freddie Mac was chartered by Congress in 1970 with a public mission to stabilize the nation's residential mortgage markets and expand opportunities for homeownership and affordable rental housing. The company's statutory mission is to provide liquidity, stability and affordability to the U.S. housin... Freddie Mac was chartered by Congress in 1970 with a public mission to stabilize the nation's residential mortgage markets and expand opportunities for homeownership and affordable rental housing. The company's statutory mission is to provide liquidity, stability and affordability to the U.S. housing market. The company participates in the secondary mortgage market by purchasing mortgage loans and mortgage-related securities for investment and by issuing guaranteed mortgage-related securities. The company does not lend money directly to homeowners. Freddie Mac is operating under a conservatorship that began on September 6, 2008, conducting business under the direction of the Federal Housing Finance Agency (FHFA). Show more

Sector
Federal Credit Agencies
Industry
Federal Credit Agencies
Headquarters
Mclean, Virginia, USA
Founded
-
Federal Home Loan Mortgage Corporation (QB) is listed in the Federal Credit Agencies sector of the OTCMarkets with ticker FMCKM. The last closing price for Federal Home Loan Mortgage (QB) was $8.05. Over the last year, Federal Home Loan Mortgage (QB) shares have traded in a share price range of $ 1.70 to $ 8.85.

Federal Home Loan Mortgage (QB) currently has 650,059,553 shares outstanding. The market capitalization of Federal Home Loan Mortgage (QB) is $5.23 billion. Federal Home Loan Mortgage (QB) has a price to earnings ratio (PE ratio) of -8.46.

FMCKM Latest News

Free Real-Time Level 2 Quotes Available in Fannie Mae and Freddie Mac at OTCMarkets.com

Free Real-Time Level 2 Quotes Available in Fannie Mae and Freddie Mac at OTCMarkets.com PR Newswire NEW YORK, Dec. 5, 2013 NEW YORK, Dec. 5, 2013 /PRNewswire/ -- Investors and traders in Fannie...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-0.2366863905338.458.67.9579528.38139772CS
42.2837.07317073176.158.856.15404247.97758734CS
124.98144.3478260873.458.852.9971764.36908304CS
264.46112.342569273.978.852.65591244.2276336CS
526.71390.116279071.728.851.7899243.11905153CS
1566.065256.448202962.3658.851.13496452.82257084CS
260-0.62-6.850828729289.0510.331.13591474.17506604CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TGICTriad Guaranty Inc (CE)
$ 0.001
(99,900.00%)
20.2k
KLMRKLM Royal Dutch Airlines (CE)
$ 0.0003
(29,900.00%)
454
DXFFDDunxin Financial Holdings Ltd (PK)
$ 3.95
(21,844.44%)
875
LLFLQLL Flooring Holdings Inc (CE)
$ 0.0002
(19,900.00%)
19.14k
RENORenovare Environmental Inc (CE)
$ 0.0001
(9,900.00%)
58.24k
UREQFDevex Resources Ltd (PK)
$ 0.0001
(-99.90%)
166
HLLPFHello Pal International Inc (CE)
$ 0.000001
(-99.90%)
36.6k
GLPTGlobal Profit Technologies Inc (CE)
$ 0.000001
(-99.86%)
8.6k
MOTSMotus GI Holdings Inc (CE)
$ 0.000001
(-99.75%)
464
KALRQKalera Public Ltd Company (CE)
$ 0.000001
(-99.50%)
539
HMBLHUMBL Inc (PK)
$ 0.0026
(136.36%)
2.24B
SPRVSupurva Healthcare Group Inc (PK)
$ 0.0002
(-33.33%)
459.92M
RDARRaadr Inc (PK)
$ 0.00145
(61.11%)
389.35M
CGACCode Green Apparel Corp (PK)
$ 0.0005
(-16.67%)
343.95M
THBDThird Bench Inc (PK)
$ 0.0001
(0.00%)
297.93M

Discussion

View Full Feed
LCJR LCJR 3 minutes ago
Most don't even know what XRP is, much less know the value. No rug pull here, everyone just needs patience and let it play out.

LCJR

XRPUSD
Info3 Info3 3 minutes ago
In general 
BMXI
misterfishman misterfishman 3 minutes ago
Nice day today.
RDAR
MartinLutherKing MartinLutherKing 3 minutes ago
8. TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
October 23 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company co
RNAZ
sluggercjb sluggercjb 4 minutes ago
lol Orca has the Doc. And all shareholders running scared all those threats are keeping everyone up at night. Orca Please stop being a bully lol ..still get a good laugh at his post
VDRM
LCP77 LCP77 4 minutes ago
I meet twice a year with my tax advisor (CPA). Once about now, for year end positioning, and then for tax season. I’ve found that to be worthwhile.
NB
bananarama bananarama 5 minutes ago
Forget about a five dollar BO. After yesterday's Web Conference, that price has already jumped to at least ten dollars. If some white knight waits to buy KBLB, they will be paying twice that amount. GO KBLB!
KBLB
nt2innovate nt2innovate 6 minutes ago
Yes. Good call. Hopefully buying will increase on the OTC with retail and family offices if they start seeing 30-40% annual growth rates going forward without dilution as you said which will cause the stock price to go up significantly.

The idea of the PEC along with Enclave having va
SDCH
northam43 northam43 6 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
jsc52033 jsc52033 6 minutes ago
actualy its down 3,397 from yesterday yet yes way ahead of Tueday which was almost none at 150,000 +
BMXI
MartinLutherKing MartinLutherKing 6 minutes ago
6.TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer usin
RNAZ
fwb fwb 7 minutes ago
If it's McDonald NEWS, we could go higher than $20.00
SOUN
XenaLives XenaLives 7 minutes ago
Define "e" as massive AI manipulation of the market as a whole....
AVXL
band aid band aid 7 minutes ago
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 7 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 7 minutes ago
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 7 minutes ago
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 8 minutes ago
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 8 minutes ago
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 9 minutes ago
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ